Target Name: ZNF626
NCBI ID: G199777
Review Report on ZNF626 Target / Biomarker Content of Review Report on ZNF626 Target / Biomarker
ZNF626
Other Name(s): zinc finger protein 626 | ZNF626 variant 1 | ZN626_HUMAN | Zinc finger protein 626 (isoform 1) | Zinc finger protein 626, transcript variant 1 | Zinc finger protein 626 | CTC-513N18.7

ZNF626: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transcription factors that play a crucial role in gene regulation. ZNF626 is a ZFP that has been identified as a potential drug target and biomarker. In this article, we will explore the biology of ZNF626 and its potential as a drug target.

The ZNF626 Protein

ZNF626 is a 21-kDa protein that is expressed in various tissues, including brain, heart, and muscle. It is composed of a N-terminal ZNF626 protein and a C-terminal C-type zinc finger domain. The ZNF626 protein has been shown to play a role in the regulation of various cellular processes, including cell growth, differentiation, and survival.

In addition to its role in gene regulation, ZNF626 has also been shown to play a role in the development and progression of certain diseases. For example, ZNF626 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

The Potential Role of ZNF626 as a Drug Target

The potential role of ZNF626 as a drug target is based on its involvement in the regulation of cellular processes that are associated with the development and progression of certain diseases. ZNF626 has been shown to play a role in the regulation of neurotransmitter release, which is critical for the function of neurons and the development of neurotransmitter-dependent disorders.

In addition, ZNF626 has also been shown to play a role in the regulation of cell survival and proliferation, which is critical for the development and progression of cancer. For example, ZNF626 has been shown to promote the survival of cancer cells by regulating the production of reactive oxygen species (ROS), which can cause damage to cellular components and contribute to the development and progression of cancer.

The Potential Role of ZNF626 as a Biomarker

The potential role of ZNF626 as a biomarker is based on its involvement in the regulation of cellular processes that are associated with the development and progression of certain diseases. ZNF626 has been shown to play a role in the regulation of neurotransmitter release, which is critical for the function of neurons and the development of neurotransmitter-dependent disorders.

In addition, ZNF626 has also been shown to play a role in the regulation of cell survival and proliferation, which is critical for the development and progression of cancer. For example, ZNF626 has been shown to promote the survival of cancer cells by regulating the production of reactive oxygen species (ROS), which can cause damage to cellular components and contribute to the development and progression of cancer.

Conclusion

In conclusion, ZNF626 is a ZFP that has been shown to play a role in the regulation of various cellular processes that are associated with the development and progression of certain diseases. The potential role of ZNF626 as a drug target and biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of ZNF626 in disease progression and to develop effective treatments.

Protein Name: Zinc Finger Protein 626

Functions: May be involved in transcriptional regulation

The "ZNF626 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF626 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF627 | ZNF628 | ZNF629 | ZNF630 | ZNF638 | ZNF639 | ZNF641 | ZNF644 | ZNF646 | ZNF648 | ZNF649 | ZNF652 | ZNF652-AS1 | ZNF653 | ZNF654 | ZNF655 | ZNF658 | ZNF658B | ZNF66 | ZNF660 | ZNF662 | ZNF663P | ZNF664 | ZNF664-RFLNA | ZNF665 | ZNF667 | ZNF667-AS1 | ZNF668 | ZNF669 | ZNF670 | ZNF670-ZNF695 | ZNF671 | ZNF672 | ZNF674 | ZNF674-AS1 | ZNF675 | ZNF676 | ZNF677 | ZNF678 | ZNF679 | ZNF680 | ZNF681 | ZNF682 | ZNF683 | ZNF684 | ZNF687 | ZNF688 | ZNF689 | ZNF69 | ZNF691 | ZNF692 | ZNF695 | ZNF696 | ZNF697 | ZNF699 | ZNF7 | ZNF70 | ZNF700 | ZNF701 | ZNF702P | ZNF703 | ZNF704 | ZNF705A | ZNF705B | ZNF705CP | ZNF705EP | ZNF705G | ZNF706 | ZNF707 | ZNF708 | ZNF709 | ZNF71 | ZNF710 | ZNF711 | ZNF713 | ZNF714 | ZNF716 | ZNF717 | ZNF718 | ZNF721 | ZNF723 | ZNF724 | ZNF726 | ZNF727 | ZNF728 | ZNF729 | ZNF730 | ZNF732 | ZNF734P | ZNF735 | ZNF736 | ZNF737 | ZNF738 | ZNF74 | ZNF740 | ZNF746 | ZNF747 | ZNF749 | ZNF750 | ZNF75A